{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:36:37Z","timestamp":1767339397121},"reference-count":21,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":5562,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1093\/annonc\/mdh409","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T19:28:40Z","timestamp":1095190120000},"page":"1447-1449","source":"Crossref","is-referenced-by-count":56,"title":["Towards understanding the peripheral T-cell lymphomas"],"prefix":"10.1016","volume":"15","author":[{"given":"J.O.","family":"Armitage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Vose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.D.","family":"Weisenburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdh409_bb0010","series-title":"World Health Organization Classification of Tumors","article-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues","year":"2001"},{"key":"10.1093\/annonc\/mdh409_bb0015","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh409_bb0020","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","article-title":"Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project","volume":"13","author":"Rudiger","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdh409_bb0025","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/ajh.1102","article-title":"Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project","volume":"67","author":"Weisenburger","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1093\/annonc\/mdh409_bb0030","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project","volume":"16","author":"Armitage","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh409_bb0035","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1200\/JCO.1989.7.12.1783","article-title":"Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma","volume":"7","author":"Armitage","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh409_bb0040","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2559.1989.tb02203.x","article-title":"The prognostic significance of immunophenotype in high-grade non-Hodgkin's lymphoma","volume":"14","author":"Brown","year":"1989","journal-title":"Histopathology"},{"key":"10.1093\/annonc\/mdh409_bb0045","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1200\/JCO.1989.7.6.725","article-title":"Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades\u2014should peripheral T-cell lymphoma be considered separately?","volume":"7","author":"Cheng","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh409_bb0050","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1349-7006.1989.tb01704.x","article-title":"T-cell phenotype is associated with decreased survival in non-Hodgkin's lymphoma","volume":"80","author":"Shimizu","year":"1989","journal-title":"Jpn J Cancer Res"},{"key":"10.1093\/annonc\/mdh409_bb0055","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/blood.V72.2.436.436","article-title":"The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype","volume":"72","author":"Lippman","year":"1988","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh409_bb0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/oxfordjournals.annonc.a057673","article-title":"Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives)","volume":"1","author":"Coiffier","year":"1990","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdh409_bb0065","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1200\/JCO.1991.9.8.1426","article-title":"Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: the Stanford experience","volume":"9","author":"Kwak","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh409_bb0070","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/10428199309148557","article-title":"Differences in clinicopathological characteristics and major prognostic factors between B-lymphoma and peripheral T-lymphoma excluding adult T-cell leukemia\/lymphoma","volume":"10","author":"Shimoyama","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdh409_bb0075","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1182\/blood.V93.11.3913","article-title":"Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma","volume":"93","author":"Gascoyne","year":"1999","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh409_bb0080","first-page":"3591","article-title":"CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology","volume":"92","author":"Brugieres","year":"1998","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh409_bb0085","first-page":"2697","article-title":"ALK+lymphoma: clinico-pathological findings and outcome","volume":"93","author":"Falini","year":"1999","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh409_bb0090","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2001.19.17.3766","article-title":"Impact of high-dose chemotherapy on peripheral T-cell lymphomas","volume":"19","author":"Rodriguez","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh409_bb0095","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/annonc\/mdg459","article-title":"High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience","volume":"14","author":"Rodriguez","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdh409_bb0100","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood.V76.2.424.424","article-title":"Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphoma","volume":"76","author":"Vose","year":"1990","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh409_bb0105","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/annonc\/mdh392","article-title":"Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification","volume":"15","author":"Savage","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdh409_bb0110","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project","volume":"9","author":"Anderson","year":"1998","journal-title":"Ann Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419510626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419510626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/15\/10\/1447\/408343\/mdh409.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T18:20:37Z","timestamp":1582222837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419510626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0923753419510626"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdh409","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}